XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 97,500 $ 164,948
Marketable securities 261,527 217,609
Accounts receivable, net of allowances and reserves of $2,702 and $2,677 as of March 31, 2022 and December 31, 2021, respectively 42,078 46,117
Deferred contract acquisition costs, current 14,345 11,921
Prepaid expenses and other current assets 11,759 8,467
Total current assets 427,209 449,062
Property and equipment, net 8,672  
Property and equipment, net   8,780
Operating right-of-use asset 6,755  
Deferred contract acquisition costs, non-current 18,023 20,887
Other long-term assets 1,469 1,760
Total assets 462,128 480,489
Current liabilities    
Accounts payable 5,149 3,123
Accrued and other current liabilities 18,707 19,011
Deferred revenue 92,127 96,225
Finance lease liabilities, current   1,768
Finance lease liabilities, current 1,637  
Operating lease liabilities, current 2,462  
Total current liabilities 120,082 120,127
Finance lease liabilities, non-current   1,648
Finance lease liabilities, non-current 1,377  
Operating lease liabilities, non-current 6,744  
Other long-term liabilities 1,379 3,624
Total liabilities 129,582 125,399
Commitments and contingencies
Stockholders’ equity    
Common stock, $0.0001 par value per share; 500,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 47,408,846 and 47,727,346 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 5 5
Additional paid-in capital 545,144 550,839
Accumulated deficit (210,998) (195,519)
Accumulated other comprehensive loss (1,605) (235)
Total stockholders’ equity (deficit) 332,546 355,090
Total liabilities and stockholders’ equity $ 462,128 $ 480,489